KRAS and cancer: Previous studies showed that Hsp90 stabilizes the serine/threonine kinase STK33 leading to an increased sensitivity of K-Ras MT cancer cells to Hsp90 inhibitors but whether this kinase has any effect on the Ras oncoprotein or Hsp90 has not been demonstrated [60].